Annual Accounts Payable
$20.33 M
-$176.00 K-0.86%
December 31, 2023
Summary
- As of February 7, 2025, NEO annual accounts payable is $20.33 million, with the most recent change of -$176.00 thousand (-0.86%) on December 31, 2023.
- During the last 3 years, NEO annual accounts payable has fallen by -$4.63 million (-18.55%).
- NEO annual accounts payable is now -18.55% below its all-time high of $24.96 million, reached on December 31, 2020.
Performance
NEO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$16.51 M
-$672.00 K-3.91%
September 30, 2024
Summary
- As of February 7, 2025, NEO quarterly accounts payable is $16.51 million, with the most recent change of -$672.00 thousand (-3.91%) on September 30, 2024.
- Over the past year, NEO quarterly accounts payable has dropped by -$3.82 million (-18.79%).
- NEO quarterly accounts payable is now -42.13% below its all-time high of $28.54 million, reached on September 30, 2021.
Performance
NEO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NEO Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.9% | -18.8% |
3 y3 years | -18.6% | -42.1% |
5 y5 years | +14.4% | -8.2% |
NEO Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -0.9% | +13.5% | -27.3% | +20.5% |
5 y | 5-year | -18.6% | +13.5% | -42.1% | +20.5% |
alltime | all time | -18.6% | >+9999.0% | -42.1% | >+9999.0% |
NeoGenomics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $16.51 M(-3.9%) |
Jun 2024 | - | $17.19 M(-6.3%) |
Mar 2024 | - | $18.34 M(-9.8%) |
Dec 2023 | $20.33 M(-0.9%) | $20.33 M(+20.9%) |
Sep 2023 | - | $16.82 M(-6.1%) |
Jun 2023 | - | $17.91 M(-21.1%) |
Mar 2023 | - | $22.71 M(+10.7%) |
Dec 2022 | $20.51 M(+14.4%) | $20.51 M(+49.6%) |
Sep 2022 | - | $13.71 M(-18.6%) |
Jun 2022 | - | $16.85 M(-17.7%) |
Mar 2022 | - | $20.48 M(+14.3%) |
Dec 2021 | $17.92 M(-28.2%) | $17.92 M(-37.2%) |
Sep 2021 | - | $28.54 M(+23.8%) |
Jun 2021 | - | $23.06 M(+21.9%) |
Mar 2021 | - | $18.92 M(-24.2%) |
Dec 2020 | $24.96 M(+27.6%) | $24.96 M(+40.8%) |
Sep 2020 | - | $17.73 M(-7.6%) |
Jun 2020 | - | $19.20 M(-6.1%) |
Mar 2020 | - | $20.45 M(+4.5%) |
Dec 2019 | $19.57 M(+10.1%) | $19.57 M(+8.7%) |
Sep 2019 | - | $18.00 M(+10.2%) |
Jun 2019 | - | $16.33 M(-1.1%) |
Mar 2019 | - | $16.51 M(-7.1%) |
Dec 2018 | $17.78 M(+70.1%) | $17.78 M(+93.3%) |
Sep 2018 | - | $9.20 M(-25.4%) |
Jun 2018 | - | $12.34 M(-5.4%) |
Mar 2018 | - | $13.05 M(+24.9%) |
Dec 2017 | $10.45 M(-37.7%) | $10.45 M(-29.5%) |
Sep 2017 | - | $14.82 M(-4.9%) |
Jun 2017 | - | $15.59 M(-24.2%) |
Mar 2017 | - | $20.58 M(+22.6%) |
Dec 2016 | $16.78 M(+34.6%) | $16.78 M(+20.0%) |
Sep 2016 | - | $13.98 M(+4.1%) |
Jun 2016 | - | $13.44 M(-12.1%) |
Mar 2016 | - | $15.29 M(+22.7%) |
Dec 2015 | $12.46 M(+98.0%) | $12.46 M(+148.0%) |
Sep 2015 | - | $5.03 M(-17.0%) |
Jun 2015 | - | $6.06 M(+10.9%) |
Mar 2015 | - | $5.46 M(-13.2%) |
Dec 2014 | $6.29 M(+50.7%) | $6.29 M(+0.1%) |
Sep 2014 | - | $6.29 M(+3.4%) |
Jun 2014 | - | $6.08 M(+29.4%) |
Mar 2014 | - | $4.70 M(+12.5%) |
Dec 2013 | $4.18 M(+15.7%) | $4.18 M(+10.5%) |
Sep 2013 | - | $3.78 M(+11.6%) |
Jun 2013 | - | $3.39 M(+15.8%) |
Mar 2013 | - | $2.92 M(-19.0%) |
Dec 2012 | $3.61 M | $3.61 M(+11.5%) |
Sep 2012 | - | $3.24 M(+3.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $3.13 M(-5.5%) |
Mar 2012 | - | $3.32 M(+31.1%) |
Dec 2011 | $2.53 M(+30.8%) | $2.53 M(+10.7%) |
Sep 2011 | - | $2.29 M(-7.2%) |
Jun 2011 | - | $2.46 M(+43.0%) |
Mar 2011 | - | $1.72 M(-10.9%) |
Dec 2010 | $1.93 M(-1.8%) | $1.93 M(+3.4%) |
Sep 2010 | - | $1.87 M(-8.8%) |
Jun 2010 | - | $2.05 M(+16.3%) |
Mar 2010 | - | $1.76 M(-10.5%) |
Dec 2009 | $1.97 M(+30.2%) | $1.97 M(-6.5%) |
Sep 2009 | - | $2.11 M(+35.6%) |
Jun 2009 | - | $1.55 M(-8.3%) |
Mar 2009 | - | $1.70 M(+12.1%) |
Dec 2008 | $1.51 M(-15.9%) | $1.51 M(-20.6%) |
Sep 2008 | - | $1.90 M(+0.1%) |
Jun 2008 | - | $1.90 M(+18.2%) |
Mar 2008 | - | $1.61 M(-10.5%) |
Dec 2007 | $1.80 M(+157.8%) | $1.80 M(+82.0%) |
Sep 2007 | - | $988.80 K(+4.2%) |
Jun 2007 | - | $949.30 K(+24.7%) |
Mar 2007 | - | $761.10 K(+9.1%) |
Dec 2006 | $697.80 K(+50.5%) | $697.80 K(+73.6%) |
Sep 2006 | - | $401.90 K(-7.2%) |
Jun 2006 | - | $433.00 K(-3.7%) |
Mar 2006 | - | $449.80 K(-3.0%) |
Dec 2005 | $463.60 K(+381.9%) | $463.60 K(+68.9%) |
Sep 2005 | - | $274.50 K(+101.2%) |
Jun 2005 | - | $136.40 K(-1.2%) |
Mar 2005 | - | $138.10 K(+43.6%) |
Dec 2004 | $96.20 K(+36.8%) | $96.20 K(+774.5%) |
Sep 2004 | - | $11.00 K(-59.6%) |
Jun 2004 | - | $27.20 K(-64.6%) |
Mar 2004 | - | $76.90 K(+9.4%) |
Dec 2003 | $70.30 K(-41.3%) | $70.30 K(+24.4%) |
Sep 2003 | - | $56.50 K(+4.1%) |
Jun 2003 | - | $54.30 K(-56.9%) |
Mar 2003 | - | $126.10 K(+5.3%) |
Dec 2002 | $119.80 K(+520.7%) | $119.80 K(-42.9%) |
Sep 2002 | - | $209.80 K(+83.1%) |
Jun 2002 | - | $114.60 K(+9.7%) |
Mar 2002 | - | $104.50 K(+441.5%) |
Dec 2001 | $19.30 K(+83.8%) | $19.30 K(+89.2%) |
Sep 2001 | - | $10.20 K(-94.1%) |
Jun 2001 | - | $173.80 K(+1691.8%) |
Mar 2001 | - | $9700.00(-7.6%) |
Dec 2000 | $10.50 K | $10.50 K(-85.4%) |
Sep 2000 | - | $71.70 K(+32.3%) |
Jun 2000 | - | $54.20 K(+140.9%) |
Mar 2000 | - | $22.50 K |
FAQ
- What is NeoGenomics annual accounts payable?
- What is the all time high annual accounts payable for NeoGenomics?
- What is NeoGenomics annual accounts payable year-on-year change?
- What is NeoGenomics quarterly accounts payable?
- What is the all time high quarterly accounts payable for NeoGenomics?
- What is NeoGenomics quarterly accounts payable year-on-year change?
What is NeoGenomics annual accounts payable?
The current annual accounts payable of NEO is $20.33 M
What is the all time high annual accounts payable for NeoGenomics?
NeoGenomics all-time high annual accounts payable is $24.96 M
What is NeoGenomics annual accounts payable year-on-year change?
Over the past year, NEO annual accounts payable has changed by -$176.00 K (-0.86%)
What is NeoGenomics quarterly accounts payable?
The current quarterly accounts payable of NEO is $16.51 M
What is the all time high quarterly accounts payable for NeoGenomics?
NeoGenomics all-time high quarterly accounts payable is $28.54 M
What is NeoGenomics quarterly accounts payable year-on-year change?
Over the past year, NEO quarterly accounts payable has changed by -$3.82 M (-18.79%)